Adi Haber

Dr. Adi Haber

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2004 in Magnetic Resonance in Chemistry
Verified
Journal Article
Closed access
PDF file
YBYael S. Balazs
Yael S. Balazs
ISIrena Saltsman
Irena Saltsman
AMAtif Mahammed
Atif Mahammed
ETElena Tkachenko
Elena Tkachenko
GGGalina Golubkov
Galina Golubkov
AHAdi Haber
Adi Haber

24 September 2008 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
AHAdi Haber
Adi Haber
AMAtif Mahammed
Atif Mahammed
BFBianca Fuhrman
Bianca Fuhrman
NVNina Volkova
Nina Volkova
RCRaymond Coleman
Raymond Coleman
ZGZeev Gross
Zeev Gross

23 January 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
AHAdi Haber
Adi Haber
SFSivan Friedman
Sivan Friedman
LLLior Lobel
Lior Lobel
TBTamar Burg-Golani
Tamar Burg-Golani
NSNadejda Sigal
Nadejda Sigal
AHAnat A Herskovits
Anat A Herskovits
The high environmental adaptability of bacteria is contingent upon their ability to sense changes in their surroundings. Bacterial pathogen entry into host poses an abrupt and dramatic environmental change, during which successful pathogens gauge multiple parameters that signal host localization. The facultative human pathogen Listeria monocytogenes flourishes in soil, water and food, and in ~50 different animals, and serves as a model for intracellular infection. L. monocytogenes identifies host entry by sensing both physical (e.g., temperature) and chemical (e.g., metabolite concentrations) factors. We report here that L-glutamine, an abundant nitrogen source in host serum and cells, serves as an environmental indicator and inducer of virulence gene expression. In contrast, ammonia, which is the most abundant nitrogen source in soil and water, fully supports growth, but fails to activate virulence gene transcription. We demonstrate that induction of virulence genes only occurs when the Listerial intracellular concentration of L-glutamine crosses a certain threshold, acting as an on/off switch: off when L-glutamine concentrations are below the threshold, and fully on when the threshold is crossed. To turn on the switch, L-glutamine must be present, and the L-glutamine high affinity ABC transporter, GlnPQ, must be active. Inactivation of GlnPQ led to complete arrest of L-glutamine uptake, reduced type I interferon response in infected macrophages, dramatic reduction in expression of virulence genes, and attenuated virulence in a mouse infection model. These results may explain observations made with other pathogens correlating nitrogen metabolism and virulence, and suggest that gauging of L-glutamine as a means of ascertaining host localization may be a general mechanism. To thrive in the human body and cause disease, bacterial pathogens rely on the expression of a battery of genes, termed virulence genes. However, to activate these genes, the bacterium must “know” that it is no longer free-roaming, and has invaded a host. Like all life forms, bacterial pathogens must acquire the four elemental building blocks (carbon, nitrogen, phosphate, sulfur). The sources for these building blocks in the bacterial host are different from those present in the environment. It therefore makes perfect “biological sense” for bacteria to use such nutrients as localization beacons. We show for the first time, that the human pathogen Listeria monocytogenes surveys the available nitrogen sources before turning on its virulence genes. L-glutamine, an abundant nitrogen source in humans, greatly induces the expression of all major virulence genes. In contrast, a nitrogen source that is prevalent in soil and water, such as ammonia, fails to do so. To better treat infectious diseases, it is vital that we understand how bacteria switch to their virulent, disease-causing state. Our results provide a significant step in this direction.

Verified
Journal Article
Open access
PDF file
YBYiftah Barsheshet
Yiftah Barsheshet
TVTali Voloshin
Tali Voloshin
BBBoris Brant
Boris Brant
GCGadi Cohen
Gadi Cohen
LKLilach Koren
Lilach Koren
YPYoram Palti
Yoram Palti
Tumor Treating Fields (TTFields) are electric fields that exert physical forces to disrupt cellular processes critical for cancer cell viability and tumor progression. TTFields induce anti-mitotic effects through the disruption of the mitotic spindle and abnormal chromosome segregation, which trigger several forms of cell death, including immunogenic cell death (ICD). The efficacy of TTFields concomitant with anti-programmed death-1 (anti-PD-1) treatment was previously shown in vivo and is currently under clinical investigation. Here, the potential of TTFields concomitant with anti- PD-1/anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA-4) or anti-programmed death-ligand 1 (anti-PD-L1) immune checkpoint inhibitors (ICI) to improve therapeutic efficacy was examined in lung tumor-bearing mice. Increased circulating levels of high mobility group box 1 protein (HMGB1) and elevated intratumoral levels of phosphorylated eukaryotic translation initiation factor 2α (p-eIF2α) were found in the TTFields-treated mice, indicative of ICD induction. The concomitant application of TTFields and ICI led to a significant decrease in tumor volume as compared to all other groups. In addition, significant increases in the number of tumor-infiltrating immune cells, specifically cytotoxic T-cells, were observed in the TTFields plus anti-PD-1/anti-CTLA-4 or anti-PD-L1 groups. Correspondingly, cytotoxic T-cells isolated from these tumors showed higher levels of IFN-γ production. Collectively, these results suggest that TTFields have an immunoactivating role that may be leveraged for concomitant treatment with ICI to achieve better tumor control by enhancing antitumor immunity.

15 January 2015 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
AHAdi Haber
Adi Haber
ZGZeev Gross
Zeev Gross
Significance: the fundamental science behind the “antioxidant therapy”, i.e., the importance of eliminating oxidizing species that may damage vital biomolecules and induce biological malfunctions, is well established. Nevertheless, quite disappointing results were reported in several recent meta-analyses that addressed the effects of vitamins and other antioxidant supplements on the many diseases that are associated with oxidative events. This emphasizes the importance of elucidating factors that might be responsible for the large gap between the hypothesis and practice. Recent advances: classical “antioxidant therapy” deals with stoichiometric antioxidants whose role is sacrificial, i.e., they are consumed on a one-to-one basis by being oxidized instead of vital biomolecules. On the other hand, catalytic antioxidants detoxify the reactive species without being permanently oxidized, and one molecule may hence disarm numerous oxidants. The benefits of catalytic antioxidants in pure chemical systems and in animal models of many diseases are quite established and have been summarized in several reviews. Critical issues: the main aim of this article is to provide a perspective on the utility of metal-based catalytic antioxidants, with a focus on those chelated by corroles, for disease prevention or treatment. Particular emphasis is on the often-ignored fact that redox-based therapeutics is potentially harmful because it may actually induce rather than decrease oxidative stress. Future directions: investigations aimed at identifying the factors that increase the antioxidant versus pro-oxidant potency of synthetic metal complexes are crucial for the optimal design of redox-based drug candidates that may be used for combating the numerous diseases that are affected by oxidative stress.

29 October 2010 in Chemical Science
Verified
Journal Article
Closed access
PDF file
AHAdi Haber
Adi Haber
MAMichael Aviram
Michael Aviram
ZGZeev Gross
Zeev Gross
Functionally defective HDL emerges as a main risk factor in cardiovascular diseases, on top of imbalanced serum lipoprotein ratios. We now show that 1-Fe, an iron(III) corrole catalytic antioxidant, spontaneously forms tightly-bound conjugates with LDL (secondarily) and HDL (primarily) of human serum. This is demonstrated by HPLC separation of serum/1-Fe mixtures and analysis of the corrole-containing fractions by UV-vis and circular dichroism spectroscopy. The LDL/1-Fe and HDL/1-Fe conjugates are resistant to functionality damaging events induced by oxidizing (copper salts) and nitrating species (peroxynitrite), as realized by heavily reduced formation of conjugated dienes, hydroperoxides, aldehydes, and nitrotyrosine. What is more, even already oxidized LDL becomes less atherogenic upon conjugation. Treatment with 1-Fe preserves the cardioprotective properties of HDL (cholesterol efflux, reduction of intracellular oxidative-stress, and inhibition of apoptosis), which are otherwise damaged under conditions of oxidative-stress. The novelty of 1-Fe relies in the unique bipolarity of the corrole macrocycle (responsible for its general affinity for lipoproteins), the affinity of the corrole-chelated iron(III) center to two histidine residues from (a particular subclass of) HDL-associated proteins, and the excellent catalytic activity regarding the decomposition of the most toxic naturally-occurring species/molecules.